Decreased heparin cofactor II activity is associated with impaired endothelial function determined by brachial ultrasonography and predicts cardiovascular events
Authors:
- Hsin-Bang LeuHLHsin-Bang Leu
- Jaw-Wen ChenJCJaw-Wen Chen
- Tao-Cheng WuTWTao-Cheng Wu
- Tse-Min LuTLTse-Min Lu
- Philip Yu-An DingPDPhilip Yu-An Ding
- Shing-Jong LinSLShing-Jong Lin
- 1 January 2007
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 114 (2) , 152-158
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Does Heparin Cofactor II Modulate Atherosclerosis and Restenosis?Circulation, 2004
- Heparin Cofactor II Is a Novel Protective Factor Against Carotid Atherosclerosis in Elderly IndividualsCirculation, 2004
- High Plasma Heparin Cofactor II Activity Is Associated With Reduced Incidence of In-Stent Restenosis After Percutaneous Coronary InterventionCirculation, 2004
- Targeting thrombin – rational drug design from natural mechanismsTrends in Pharmacological Sciences, 2003
- Heparin cofactor II inhibits arterial thrombosis after endothelial injuryJournal of Clinical Investigation, 2002
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arteryJACC, 2002
- Molecular Mechanism of Type I Congenital Heparin Cofactor (HC) II Deficiency Caused by a Missense Mutation at Reactive P2 Site: HC II TokushimaThrombosis and Haemostasis, 2001
- A player of many parts: The spotlight falls on thrombin's structureThrombosis Research, 1993
- Thrombin receptor expression in normal and atherosclerotic human arteries.Journal of Clinical Investigation, 1992
- The Pathogenesis of Coronary Artery Disease and the Acute Coronary SyndromesNew England Journal of Medicine, 1992